Please use this identifier to cite or link to this item: doi:10.22028/D291-38314
Volltext verfügbar? / Dokumentlieferung
Title: IP3-dependent Ca2+ signals are tightly controlled by Cavβ3, but not by Cavβ1, 2 and 4
Author(s): Belkacemi, Anouar
Beck, Andreas
Wardas, Barbara
Weissgerber, Petra
Flockerzi, Veit
Language: English
Title: Cell Calcium
Volume: 104
Publisher/Platform: Elsevier
Year of Publication: 2022
Free key words: Voltage-gated Ca2+ channels
Cavβ subunits
IP3
Ca2+release
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Independent of its function as a subunit of voltage-gated Ca2+ channels, the Cavβ3 subunit desensitizes fibroblasts and pancreatic β-cells to low concentrations of inositol-1,4,5-trisphosphate (IP3). This alters agonist-induced Ca2+ signaling and cellular functions, for example, insulin secretion and wound healing. A total of four Cavβ subunits exist, Cavβ1, Cavβ2, Cavβ3, and Cavβ4. To investigate whether the other Cavβ subunits, like Cavβ3, can desensitize cells to IP3 and thereby modulate Ca2+ signaling, we expressed the cDNAs of Cavβ1, Cavβ2, Cavβ3, and Cavβ4 in COS-7 cells lacking endogenous Cavβ proteins. ATP stimulation of these cells results in the release of Ca2+ from intracellular stores. This receptor-mediated Ca2+ release is significantly decreased by Cavβ3 but not by Cavβ1, Cavβ2, and Cavβ4. Electrophysiological recordings of voltage-dependent Ca2+ currents from fibroblasts show a small Ca2+ current, the amplitude of which is slightly but not significantly smaller in fibroblasts from Cavβ2 gene-deficient animals than in fibroblasts from wild-type animals. Compared with fibroblasts from wild-type animals, Ca2+ release is not significantly increased in Cavβ2-deficient fibroblasts, in contrast to Ca2+ release in Cavβ3-deficient fibroblasts. In summary, our results show that desensitization of cells to low concentrations of IP3 is a specific property of Cavβ3 that is not shared by other Cavβ subunits.
DOI of the first publication: 10.1016/j.ceca.2022.102573
URL of the first publication: http://dx.doi.org/10.1016/j.ceca.2022.102573
Link to this record: urn:nbn:de:bsz:291--ds-383147
hdl:20.500.11880/34571
http://dx.doi.org/10.22028/D291-38314
ISSN: 0143-4160
Date of registration: 30-Nov-2022
Faculty: M - Medizinische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
Professorship: M - Prof. Dr. Veit Flockerzi
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons